参考文献/References:
[1] VERGARA N,DE MIER M,RODELO-HAAD C,et al.The direct effect of fibroblast growth factor 23 on vascular smooth muscle cell phenotype and function[J].Nephrol Dial Transplant,2023,38(2):322-343.
[2] QIAN Z J, LI H C, YANG H Y,et al.Osteocalcin attenuates oligodendrocyte differentiation and myelination via GPR37 signaling in the mouse brain[J].Sci Adv,2021,7(43):abi5811.
[3] LARA S,SUMER A A,COURTNEY L,et al.Serum osteocalcin is an important predictor of central and total adiposity and insulin resistance[J].Current Developments in Nutrition,2022,6(1):49.
[4] KANG H,SHIN H J,AN H S,et al.Role of lipocalin-2 in amyloid-β oligomer-induced mouse model of Alzheimer's disease[J].Antioxidants(Basel),2021,10(11):1657.
[5] ZHENG S,WEI J,CHEN P,et al.Sclerostin aggravates cardiac remodeling after myocardial infarction by inhibition of Wnt/β-catenin signaling pathway[J].J Thorac Dis,2022,14(5):1563-1577.
[6] NAKATANI S,NAKATANI A,MORI K,et al.Fibroblast growth factor 23 as regulator of vitamin D metabolism[J].Adv Exp Med Biol,2022,1362:47-54.
[7] KOMORI T.What is the function of osteocalcin?[J].J Oral Biosci,2020,62(3):223-227.
[8] XU C,WU Y,LIU N.Osteopontin in autoimmune disorders:current knowledge and future perspective[J].Inflammopharmacology,2022,30(2):385-396.
[9] KIKUCHI A,MATSUMOTO S,SADA R.Dickkopf signaling beyond Wnt-mediated biology[J].Semin Cell Dev Biol,2022,125:55-65.
[10] MOSIALOU I,SHIKHEL S,LIU J M,et al.MC4R-dependent suppression of appetite by bone-derived lipocalin 2[J].Nature,2017,543(7645):385-390.
[11] PARKER L,ANG T,MORRISON D J,et al.Prior aerobic exercise mitigates the decrease in serum osteoglycin and lipocalin-2 following high-glucose mixed-nutrient meal ingestion in young men[J].Am J Physiol Endocrinol Metab,2022,323(3):E319-E332.
[12] MA C,YU R,LI J,et al.Cross-sectional study and bioinformatics analysis to reveal the correlations of osteoporosis in patients with Parkinson's disease[J].Exp Gerontol,2023,173:112111.
[13] KWON M J,KIM J H,KIM J H,et al.The occurrence of Alzheimer's disease and Parkinson's disease in individuals with osteoporosis:a longitudinal follow-up study using a national health screening database in Korea[J].Front Aging Neurosci,2021,13:786337.
[14] HE B,LYU Q,YIN L,et al.Depression and osteoporosis:a mendelian randomization study[J].Calcif Tissue Int,2021,109(6):675-684.
[15] OURY F,KHRIMIAN L,DENNY C A,et al.Maternal and offspring pools of osteocalcin influence brain development and functions[J].Cell,2013,155(1):228-241.
[16] KHRIMIAN L,OBRI A,RAMOS-BROSSIER M,et al.Gpr158 mediates osteocalcin's regulation of cognition[J].J Exp Med,2017,214(10):2859-2873.
[17] LEE S,KIM J H,KIM J H,et al.Lipocalin-2 is a chemokine inducer in the central nervous system:role of chemokine ligand 10(CXCL10)in lipocalin-2-induced cell migration[J].J Biol Chem,2011,286(51):43855-43870.
[18] KIM J H,KO P W,LEE H W,et al.Astrocyte-derived lipocalin-2 mediates hippocampal damage and cognitive deficits in experimental models of vascular dementia[J].Glia,2017,65(9):1471-1490.
[19] BI F,HUANG C,TONG J,et al.Reactive astrocytes secrete lcn2 to promote neuron death[J].Proc Natl Acad Sci USA,2013,110(10):4069-4074.
[20] VAY S U,OLSCHEWSKI D N,PETEREIT H,et al.Osteopontin regulates proliferation,migration,and survival of astrocytes depending on their activation phenotype[J].J Neurosci Res,2021,99(11):2822-2843.
[21] RENTSENDORJ A,SHEYN J,FUCHS D T,et al.A novel role for osteopontin in macrophage-mediated amyloid-beta clearance in Alzheimer's models[J].Brain Behav Immun,2018,67:163-180.
[22] CHEN H,SHANG D,WEN Y,et al.Bone-derived modulators that regulate brain function:emerging therapeutic targets for neurological disorders[J].Front Cell Dev Biol,2021,9:683457.
[23] XU D,LI F,XUE G,et al.Effect of Wnt signaling pathway on neurogenesis after cerebral ischemia and its therapeutic potential[J].Brain Res Bull,2020,164:1-13.
[24] MENET R,BOURASSA P,CALON F,et al.Dickkopf-related protein-1 inhibition attenuates amyloid-β pathology associated to Alzheimer's disease[J].Neurochem Int,2020,141:104881.
[25] ORTIZ-MATAMOROS A,ARIAS C.Chronic infusion of Wnt7a,Wnt5a and Dkk-1 in the adult hippocampus induces structural synaptic changes and modifies anxiety and memory performance[J].Brain Res Bull,2018,139:243-255.
[26] HYGUM K,STARUP-LINDE J,LANGDAHL B L.Diabetes and bone[J].Osteoporos Sarcopenia,2019,5(2):29-37.
[27] LEI H,LIU J,WANG W,et al.Association between osteocalcin,a pivotal marker of bone metabolism,and secretory function of islet β cells and α cells in Chinese patients with type 2 diabetes mellitus:an observational study[J].Diabetol Metab Syndr,2022,14(1):160.
[28] ZHANG Y,LIU M,CHEN H,et al.Associations between circulating bone-derived hormones lipocalin 2,osteocalcin,and glucose metabolism in acromegaly[J].J Endocrinol Invest,2020,43(9):1309-1316.
[29] LEE N K,SOWA H,HINOI E,et al.Endocrine regulation of energy metabolism by the skeleton[J].Cell,2007,130(3):456-469.
[30] LACOMBE J,AL R O,LOTER L,et al.Measurement of bioactive osteocalcin in humans using a novel immunoassay reveals association with glucose metabolism and beta-cell function[J].Am J Physiol Endocrinol Metab,2020,318(3):E381-E391.
[31] TAKASHI Y,KOGA M,MATSUZAWA Y,et al.Undercarboxylated osteocalcin can predict insulin secretion ability in type 2 diabetes[J].J Diabetes Investig,2017,8(4):471-474.
[32] YE X,YU R,JIANG F,et al.Osteocalcin and risks of incident diabetes and diabetic kidney disease:a 4.6-year prospective cohort study[J].Diabetes Care,2022,45(4):830-836.
[33] VAN DER VAART A,YEUNG S,VAN DIJK P R,et al.Phosphate and fibroblast growth factor 23 in diabetes[J].Clin Sci(Lond),2021,135(14):1669-1687.
[34] NAKASHIMA A,YOKOYAMA K,KAWANAMI D,et al.Association between resistin and fibroblast growth factor 23 in patients with type 2 diabetes mellitus[J].Sci Rep,2018,8(1):13999.
[35] DANIELE G,WINNIER D,MARI A,et al.Sclerostin and insulin resistance in prediabetes:evidence of a cross talk between bone and glucose metabolism[J].Diabetes Care,2015,38(8):1509-1517.
[36] KIM S P,FREY J L,LI Z,et al.Sclerostin influences body composition by regulating catabolic and anabolic metabolism in adipocytes[J].Proc Natl Acad Sci USA,2017,114(52):E11238-E11247.
[37] YU O H,RICHARDS B,BERGER C,et al.The association between sclerostin and incident type 2 diabetes risk:a cohort study[J].Clin Endocrinol(Oxf),2017,86(4):520-525.
[38] 戚晓楠,姚啸生,郑洪新,等.基于“骨肉不相亲”理论骨与骨骼肌关系的探讨[J].中国骨质疏松杂志,2019,25(10):1487-1492.
[39] 宗博艺,李世昌,孙朋,等.骨骼源性因子对肌骨“Crosstalk”作用机制的研究进展[J].中国骨质疏松杂志,2020,26(1):118-123.
[40] MERA P,LAUE K,FERRON M,et al.Osteocalcin signaling in myofibers is necessary and sufficient for optimum adaptation to exercise[J].Cell Metab,2017,25(1):218.
[41] SHEN H,GRIMSTON S,CIVITELLI R,et al.Deletion of connexin43 in osteoblasts/osteocytes leads to impaired muscle formation in mice[J].J Bone Miner Res,2015,30(4):596-605.
[42] TSUKA S,AONUMA F,HIGASHI S,et al.Promotion of insulin-induced glucose uptake in C2C12 myotubes by osteocalcin[J].Biochem Biophys Res Commun,2015,459(3):437-442.
[43] SATO C,ISO Y,MIZUKAMI T,et al.Fibroblast growth factor-23 induces cellular senescence in human mesenchymal stem cells from skeletal muscle[J].Biochem Biophys Res Commun,2016,470(3):657-662.
[44] LI D J,FU H,ZHAO T,et al.Exercise-stimulated FGF23 promotes exercise performance via controlling the excess reactive oxygen species production and enhancing mitochondrial function in skeletal muscle[J].Metabolism,2016,65(5):747-756.
[45] FUKASAWA H,ISHIGAKI S,KINOSHITA-KATAH-ASHI N,et al.Plasma levels of fibroblast growth factor-23 are associated with muscle mass in haemodialysis patients[J].Nephrology(Carlton),2014,19(12):784-790.
[46] LEE J H,YOON J Y,LEE Y B.The use of intravenous zoledronate may reduce retear rate after rotator cuff repair in older female patients with osteoporosis:a first in-human prospective study[J].J Clin Med,2022,11(3):836.